OCV Partners is a Los Angeles based venture capital firm that invests in companies with differentiated technologies in compelling target markets.
With our decades of company-building experience, our overriding objective is to use our unique expertise to identify or create an asymmetric advantage when backing winning teams.
Our core focus sectors are Technology (SaaS, FinTech, and PropTech) and Healthcare (Healthcare SaaS, Digital Health, MedTech, and BioTech).
We are former Founders with a track record of success
We aim to create asymmetric advantages for our Founders
We are flexible capital – we like to lead, but it is not a requirement
Focus Sector: Technology
We invest in brilliant teams building disruptive technology. As former Founders, we have grown businesses from the earliest stages to IPOs and beyond. We invest in:
- Subscription software where we have expertise in growing and acquiring over 165 unique software companies
- Recurring revenue business models where our past experience reveals an asymmetric advantage
- SaaS, Fintech, and PropTech, which are areas where we have previously built companies
Focus Sector: Healthcare
We are scientists and healthcare entrepreneurs who love partnering with Founders building companies that need to exist.
We believe our investments should be challenging and changing what is possible for human health and disease.
We focus on entrepreneurs building disruptive platforms in Healthcare SaaS, Digital Health, MedTech, and Biotech.
We invest in companies that:
- Enable precision or targeted approaches to improve patient lives
- Empower better treatment decisions and optimize workflows
- Remove barriers to care and improve equitable access
- Expedite the discovery of new treatments
Our deep technical and operational expertise uniquely positions us to invest in and support startups at the intersection of healthcare and technology.
News
ByHeart Announces $95M in New Financing On The Heels of Rapid Growth and the Completion of its End-to-End Manufacturing, Furthering its Commitment to Transforming the Infant Formula Industry
With the addition of two new production facilities in Oregon and Iowa, ByHeart is now positioned to triple its supply capacity to support families nationwide NEW YORK, May 13, 2024 /PRNewswire/ -- ByHeart, the next-generation infant nutrition company, today announced...
Rad AI Closes $50 Million to Empower Physicians with AI
Led by Khosla Ventures; investment to expand Rad AI’s generative AI solutions across health systems globally SAN FRANCISCO, May 7, 2024 /PRNewswire/ -- Rad AI, a leader in generative AI for healthcare, today announced it raised $50 million in Series B financing. The...
NorthStandard, Leading Maritime Insurer, Partners with Orca AI to Offer Safety Benefits of Situational Awareness Platform
NorthStandard and Orca AI have entered an exclusive partnership that will see the global marine insurer encourage its members to adopt Orca AI’s market-leading automated situational awareness solution. Orca AI’s situational awareness platform is designed to ensure...
ByHeart Announces $95M in New Financing On The Heels of Rapid Growth and the Completion of its End-to-End Manufacturing, Furthering its Commitment to Transforming the Infant Formula Industry
With the addition of two new production facilities in Oregon and Iowa, ByHeart is now positioned to triple its supply capacity to support families nationwide NEW YORK, May 13, 2024 /PRNewswire/ -- ByHeart, the next-generation infant nutrition company, today announced...
Rad AI Closes $50 Million to Empower Physicians with AI
Led by Khosla Ventures; investment to expand Rad AI’s generative AI solutions across health systems globally SAN FRANCISCO, May 7, 2024 /PRNewswire/ -- Rad AI, a leader in generative AI for healthcare, today announced it raised $50 million in Series B financing. The...
With our decades of company building experience, we look to create asymmetric advantages when backing winning teams.